Interestingly, a 50% risk reduction of AD development has been associated with the APOE3-Jacksonville (V236E) variant and APOE4 R251G variant,5 and the protective mechanisms arising from a single amino acid substitution in R251G variant should be explored. This evidence concerns the gene APOE and Alzheimer disease.